These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6437836)

  • 1. Enhanced fibrinolytic activity during cardiopulmonary bypass in open-heart surgery in man is caused by extrinsic (tissue-type) plasminogen activator.
    Stibbe J; Kluft C; Brommer EJ; Gomes M; de Jong DS; Nauta J
    Eur J Clin Invest; 1984 Oct; 14(5):375-82. PubMed ID: 6437836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effect of smoking on fibrinolysis: increase in the activity level of circulating extrinsic (tissue-type) plasminogen activator.
    Allen RA; Kluft C; Brommer EJ
    Eur J Clin Invest; 1984 Oct; 14(5):354-61. PubMed ID: 6437833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass.
    Ray MJ; Marsh NA; Hawson GA
    Blood Coagul Fibrinolysis; 1994 Oct; 5(5):679-85. PubMed ID: 7865673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrinsic plasminogen activator: a new principle in fibrinolysis.
    Lijnen HR
    Behring Inst Mitt; 1983 Aug; (73):43-55. PubMed ID: 6236789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery.
    Tanaka K; Takao M; Yada I; Yuasa H; Kusagawa M; Deguchi K
    J Cardiothorac Anesth; 1989 Apr; 3(2):181-8. PubMed ID: 2535275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-type plasminogen activator and fibrin monomers synergistically cause platelet dysfunction during retransfusion of shed blood after cardiopulmonary bypass.
    de Haan J; Schönberger J; Haan J; van Oeveren W; Eijgelaar A
    J Thorac Cardiovasc Surg; 1993 Dec; 106(6):1017-23. PubMed ID: 8246533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen--levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and C1-inactivator.
    Jespersen J; Kluft C
    Thromb Haemost; 1985 Aug; 54(2):454-9. PubMed ID: 2417350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemostatic defects induced by cardiopulmonary bypass.
    Bick RL; Arbegast N; Crawford L; Holterman M; Adams T; Schmalhorst W
    Vasc Surg; 1975; 9(4):228-43. PubMed ID: 1106031
    [No Abstract]   [Full Text] [Related]  

  • 9. Lack of correlation between blood fibrinolysis and the immediate or post-operative blood loss in transurethral resection of the prostate.
    Nielsen JD; Gram J; Fabrin K; Holm-Nielsen A; Jespersen J
    Br J Urol; 1997 Jul; 80(1):105-10. PubMed ID: 9240188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery.
    Kojima T; Gando S; Morimoto Y; Mashio H; Goda Y; Kawahigashi H; Kemmotsu O
    Thromb Res; 2001 Dec; 104(5):301-7. PubMed ID: 11738071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration.
    Collen D; Stassen JM; Verstraete M
    J Clin Invest; 1983 Feb; 71(2):368-76. PubMed ID: 6681615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression of tissue plasminogen activator (t-PA) activity and rise of t-PA inhibition and acute phase reactants in blood of patients with acute myocardial infarction (AMI).
    Gram J; Kluft C; Jespersen J
    Thromb Haemost; 1987 Oct; 58(3):817-21. PubMed ID: 2448888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass.
    Tabuchi N; de Haan J; Boonstra PW; van Oeveren W
    J Thorac Cardiovasc Surg; 1993 Nov; 106(5):828-33. PubMed ID: 8231204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra- and postoperative fibrinolysis in patients undergoing cardiopulmonary bypass surgery.
    Páramo JA; Rifón J; Llorens R; Casares J; Paloma MJ; Rocha E
    Haemostasis; 1991; 21(1):58-64. PubMed ID: 1907591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the type of surgical operation influence the changes observed in fibrinolytic activity after cardiopulmonary bypass?
    Sánchez JM; Martin JM
    Chest; 1997 Sep; 112(3):856-7. PubMed ID: 9315832
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhanced effective fibrinolysis following the neutralization of heparin in open heart surgery increases the risk of post-surgical bleeding.
    Gram J; Janetzko T; Jespersen J; Bruhn HD
    Thromb Haemost; 1990 Apr; 63(2):241-5. PubMed ID: 2114043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the human tissue plasminogen activator in plasma from different species.
    Häggroth L; Mattsson C; Friberg J
    Thromb Res; 1984 Mar; 33(6):583-94. PubMed ID: 6202022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in fibrinolytic activity during the course of a single hemodialysis session.
    Kurz H; Lerner RG; Weseley S; Nelson JC
    Clin Nephrol; 1985 Jul; 24(1):1-4. PubMed ID: 4040447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tissue type plasminogen activator and its inhibition in blood of patients operated on for prostatic carcinoma].
    Iwan-Zietek I; Zietek Z; Kotschy M; Rość D; Tyloch F
    Pol Tyg Lek; 1996 Feb; 51(6-9):91-3. PubMed ID: 8756741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.